These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends. Boussen H, Bouzaiene H, Ben Hassouna J, Dhiab T, Khomsi F, Benna F, Gamoudi A, Mourali N, Hechiche M, Rahal K, Levine PH. Cancer; 2010 Jun 01; 116(11 Suppl):2730-5. PubMed ID: 20503401 [Abstract] [Full Text] [Related]
5. Histopathological features of rapidly progressing breast carcinoma in Tunisia: a study of 94 cases. Costa J, Webber BL, Levine PH, Muenz L, O'Conor GT, Tabbane F, Belhassen S, Kamaraju LS, Mourali N. Int J Cancer; 1982 Jul 15; 30(1):35-7. PubMed ID: 6288578 [Abstract] [Full Text] [Related]
6. A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer. Cunningham TJ, Daut D, Wolfgang PE, Mellyn M, Maciolek S, Sponzo RW, Horton J. Cancer; 1976 Apr 15; 37(4):1696-1700. PubMed ID: 1260685 [Abstract] [Full Text] [Related]
7. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. Burdick JF, Wells SA, Herberman RB. Surg Gynecol Obstet; 1975 Nov 15; 141(5):779-94. PubMed ID: 128144 [Abstract] [Full Text] [Related]
8. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Tabbane F, Muenz L, Jaziri M, Cammoun M, Belhassen S, Mourali N. Cancer; 1977 Jul 15; 40(1):376-82. PubMed ID: 880564 [Abstract] [Full Text] [Related]
9. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 3. The frequency, duration, and cross reactivity of this phenomenon in patients with breast cancer, and its correlation with survival. Stewart TH, Orizaga M. Cancer; 1971 Dec 15; 28(6):1472-8. PubMed ID: 5127795 [No Abstract] [Full Text] [Related]
10. Delayed hypersensitivity reactions in patients with breast cancer. Boeva M, Donchev T, Markova R, Christov I. Neoplasma; 1978 Dec 15; 25(6):733-6. PubMed ID: 752118 [Abstract] [Full Text] [Related]
12. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Mourali N, Muenz LR, Tabbane F, Belhassen S, Bahi J, Levine PH. Cancer; 1980 Dec 15; 46(12):2741-6. PubMed ID: 7448713 [Abstract] [Full Text] [Related]
13. Delayed cutaneous hypersensitivity reaction in breast cancer patients. Jain P, Khanna NN. J Indian Med Assoc; 1988 Jan 15; 86(1):5-7. PubMed ID: 3288701 [No Abstract] [Full Text] [Related]
14. Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells. Alford C, Hollinshead AC, Heberman RB. Ann Surg; 1973 Jul 15; 178(1):20-4. PubMed ID: 4717706 [No Abstract] [Full Text] [Related]
15. Local delayed cutaneous hypersensitivity reactions in breast cancer patients with and without removal of axillary lymph nodes. Schick PM, Shabot MM, Block JB, Rosenbloom BE, Burleigh J, Pilch YH. Am J Surg; 1976 Jul 15; 132(1):40-5. PubMed ID: 782264 [Abstract] [Full Text] [Related]
16. [Immunologic reactivity of breast cancer patients]. Semiglazov VF, Kondrat'ev VB, Mar'enko AI, L'vovich EG, Sofronov BN. Vopr Onkol; 1978 Jul 15; 24(8):74-9. PubMed ID: 695430 [Abstract] [Full Text] [Related]
18. [Delayed hypersensitivity in pediatric patients with cancer]. Rivera Luna R, Munford DM, Wilbur JR. Bol Med Hosp Infant Mex; 1977 Jul 15; 34(6):11-71. PubMed ID: 588329 [Abstract] [Full Text] [Related]
19. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients. Fossati G, Canevari S, Pierotti MA, Vezzoni P, Porta GD, Vaglini M. J Natl Cancer Inst; 1979 Jun 15; 62(6):1381-5. PubMed ID: 286110 [No Abstract] [Full Text] [Related]
20. Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers. Bolton PM, Mander AM, Davidson JM, James SL, Newcombe RG, Hughes LE. Br Med J; 1975 Jul 05; 3(5974):18-20. PubMed ID: 1131654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]